Blume Capital Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Blume Capital Management’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5	Closed	-$36	–	319
2023 Q4	$36	Hold	5	–	–	﹤0.01%	313
2023 Q3	$40	Hold	5	–	–	﹤0.01%	315
2023 Q2	$28	Hold	5	–	–	﹤0.01%	320
2023 Q1	$29	Hold	5	–	–	﹤0.01%	313
2022 Q4	$35	Hold	5	–	–	﹤0.01%	318
2022 Q3	$0	Hold	5	–	–	﹤0.01%	322
2022 Q2	$0	Hold	5	–	–	﹤0.01%	327
2022 Q1	$0	Hold	5	–	–	﹤0.01%	319
2021 Q4	$0	Hold	5	–	–	﹤0.01%	309
2021 Q3	$0	Hold	5	–	–	﹤0.01%	305
2021 Q2	$0	Hold	5	–	–	﹤0.01%	288
2021 Q1	$0	Buy	+5	New	+$231	﹤0.01%	268

Other funds holding MSOS

CSD

Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

SCP

Sender Company & Partners New York $345M AUM 41.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Blume Capital Management's MSOS Position: Q1 2024 in Review

Blume Capital Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2024, closing a stake of 5 shares — an estimated $36 sold.

Blume Capital Management first reported a position in MSOS in Q1 2021 and held it in 12 quarters. The position peaked at $40 in Q3 2023. 187 funds tracked by Wall St. Rank hold MSOS as of Q1 2024.

Blume Capital Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2024 after selling out during the quarter.
Blume Capital Management sold 5 AdvisorShares Pure US Cannabis ETF shares in Q1 2024, an estimated $36.
Blume Capital Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2021 and held it in 12 quarters.
Blume Capital Management's AdvisorShares Pure US Cannabis ETF position peaked at $40 in Q3 2023.
187 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2024.

Based on Blume Capital Management's 13F filing for Q1 2024, filed 2 May 2024.